Efficient in vivo gene expression by trans-splicing adeno-associated viral vectors
Open Access
- 9 October 2005
- journal article
- research article
- Published by Springer Nature in Nature Biotechnology
- Vol. 23 (11) , 1435-1439
- https://doi.org/10.1038/nbt1153
Abstract
Although adeno-associated virus (AAV)-mediated gene therapy has been hindered by the small viral packaging capacity of the vector, trans-splicing AAV vectors are able to package twice the size of the vector genome. Unfortunately, the efficiency of current trans-splicing vectors is very low. Here we show that rational design of the gene splitting site has a profound influence on trans-splicing vector-mediated gene expression. Using mRNA accumulation as a guide, we generated a set of efficient trans-splicing vectors and achieved widespread expression of the 6-kb ΔH2-R19 mini-dystrophin gene in skeletal muscle of mdx mice, a model for Duchenne muscular dystrophy. The dystrophic phenotype was ameliorated in both adult and aged mice. This demonstrates the use of trans-splicing vectors to efficiently express a large therapeutic structural protein. This strategy should be applicable to other large therapeutic genes or large transcription regulatory elements.Keywords
This publication has 30 references indexed in Scilit:
- Inactivation of the SR Protein Splicing Factor ASF/SF2 Results in Genomic InstabilityCell, 2005
- Inverted Terminal Repeat Sequences Are Important for Intermolecular Recombination and Circularization of Adeno-Associated Virus GenomesJournal of Virology, 2005
- Full-length dystrophin expression in half of the heart cells ameliorates -isoproterenol-induced cardiomyopathy in mdx miceHuman Molecular Genetics, 2004
- Microdystrophin Gene Therapy of Cardiomyopathy Restores Dystrophin-Glycoprotein Complex and Improves Sarcolemma Integrity in the Mdx Mouse HeartCirculation, 2003
- Efficient Trans-Splicing in the Retina Expands the Utility of Adeno-Associated Virus as a Vector for Gene TherapyHuman Gene Therapy, 2003
- Expression of Human Factor VIII by Splicing between Dimerized AAV VectorsMolecular Therapy, 2002
- Listening to silence and understanding nonsense: exonic mutations that affect splicingNature Reviews Genetics, 2002
- Expanding AAV Packaging Capacity with Trans-splicing or Overlapping Vectors: A Quantitative ComparisonMolecular Therapy, 2001
- Evidence for gene transfer and expression of factor IX in haemophilia B patients treated with an AAV vectorNature Genetics, 2000
- Quantitative Analysis of the Packaging Capacity of Recombinant Adeno-Associated VirusHuman Gene Therapy, 1996